Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform.
Saved in:
| Title: | Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform. |
|---|---|
| Authors: | Mosquera Orgueira A; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain., Gonzalez Perez MS; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain., D'Agostino M; Division of Hematology, AOU Città della Salute e della Scienza di Torino University of Torino Torino Italy.; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy., Cairns DA; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom., Larocca A; Department of Molecular Biotechnology and Health Sciences, Division of Hematology University of Torino Torino Italy., Palacios JJL; Hospital Universitario 12 de Octubre CIBER-ONC CB16/12/00369, CNIO Madrid Spain., Wester R; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Bertsch U; National Center for Tumor Diseases Heidelberg Heidelberg Germany.; Department of Medicine V, Heidelberg Myeloma Center University Hospital Heidelberg Heidelberg Germany., Waage A; Institute of Clinical and Molecular Medicine Norwegian University of Science and Technology and St. Olavs Hospital Trondheim Norway., Zamagni E; Department of Medical and Surgical Sciences, 'Seràgnoli' Institute of Hematology University of Bologna Bologna Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy., Pérez Míguez C; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain., Rojas Martínez JA; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain., Mai EK; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg GMMG Study Group Heidelberg Germany., Crucitti D; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain., Salwender H; Asklepios Tumorzentrum Hamburg Asklepios Hospital Hamburg Altona and St. Georg Hamburg Germany., Dall'Olio D; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy., Castellani G; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy., Piñeiro Fiel M; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain., Bringhen S; AOU Città della Salute e della Scienza di Torino Torino Italy., Zweegman S; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands., Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna Institute of Hematology 'L. e A. Seràgnoli' Bologna Italy.; Department of Medical and Surgical Sciences University of Bologna Bologna Italy., Iqbal S; Medical Information Scientific Engagement Johnson & Johnson Innovative Medicines New York New York United States., Hernandez Rivas JM; Department of Medicine, Cancer Research Center (IBMCC, USAL-CSIC), Institute of Biomedical Research of Salamanca (IBSAL) University of Salamanca Salamanca Spain., Bruno B; Division of Hematology, AOU Città della Salute e della Scienza di Torino University of Torino Torino Italy.; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy., Cook G; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom., Kaiser MF; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.; The Institute of Cancer Research and the Royal Marsden Hospital London United Kingdom., Goldschmidt H; National Center for Tumor Diseases Heidelberg Heidelberg Germany.; Department of Medicine V, Heidelberg Myeloma Center University Hospital Heidelberg Heidelberg Germany., Van De Donk NWCJ; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands., Jackson G; Department of Haematology Newcastle University Newcastle Upon Tyne United Kingdom., San-Miguel JF; Clínica Universidad de Navarra CIMA, IDISNA, CIBERONC (CB16/12/00369) Pamplona Spain., Boccadoro M; European Myeloma Network (EMN) Italy., Mateos MV; Department of Medicine, Cancer Research Center (IBMCC, USAL-CSIC), Institute of Biomedical Research of Salamanca (IBSAL) University of Salamanca Salamanca Spain., Sonneveld P; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands. |
| Source: | HemaSphere [Hemasphere] 2025 Oct 09; Vol. 9 (10), pp. e70228. Date of Electronic Publication: 2025 Oct 09 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41080508 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mosquera+Orgueira+A%22">Mosquera Orgueira A</searchLink>; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez+Perez+MS%22">Gonzalez Perez MS</searchLink>; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.<br /><searchLink fieldCode="AU" term="%22D'Agostino+M%22">D'Agostino M</searchLink>; Division of Hematology, AOU Città della Salute e della Scienza di Torino University of Torino Torino Italy.; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.<br /><searchLink fieldCode="AU" term="%22Cairns+DA%22">Cairns DA</searchLink>; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.<br /><searchLink fieldCode="AU" term="%22Larocca+A%22">Larocca A</searchLink>; Department of Molecular Biotechnology and Health Sciences, Division of Hematology University of Torino Torino Italy.<br /><searchLink fieldCode="AU" term="%22Palacios+JJL%22">Palacios JJL</searchLink>; Hospital Universitario 12 de Octubre CIBER-ONC CB16/12/00369, CNIO Madrid Spain.<br /><searchLink fieldCode="AU" term="%22Wester+R%22">Wester R</searchLink>; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; National Center for Tumor Diseases Heidelberg Heidelberg Germany.; Department of Medicine V, Heidelberg Myeloma Center University Hospital Heidelberg Heidelberg Germany.<br /><searchLink fieldCode="AU" term="%22Waage+A%22">Waage A</searchLink>; Institute of Clinical and Molecular Medicine Norwegian University of Science and Technology and St. Olavs Hospital Trondheim Norway.<br /><searchLink fieldCode="AU" term="%22Zamagni+E%22">Zamagni E</searchLink>; Department of Medical and Surgical Sciences, 'Seràgnoli' Institute of Hematology University of Bologna Bologna Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.<br /><searchLink fieldCode="AU" term="%22Pérez+Míguez+C%22">Pérez Míguez C</searchLink>; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.<br /><searchLink fieldCode="AU" term="%22Rojas+Martínez+JA%22">Rojas Martínez JA</searchLink>; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg GMMG Study Group Heidelberg Germany.<br /><searchLink fieldCode="AU" term="%22Crucitti+D%22">Crucitti D</searchLink>; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.<br /><searchLink fieldCode="AU" term="%22Salwender+H%22">Salwender H</searchLink>; Asklepios Tumorzentrum Hamburg Asklepios Hospital Hamburg Altona and St. Georg Hamburg Germany.<br /><searchLink fieldCode="AU" term="%22Dall'Olio+D%22">Dall'Olio D</searchLink>; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy.<br /><searchLink fieldCode="AU" term="%22Castellani+G%22">Castellani G</searchLink>; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy.<br /><searchLink fieldCode="AU" term="%22Piñeiro+Fiel+M%22">Piñeiro Fiel M</searchLink>; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.<br /><searchLink fieldCode="AU" term="%22Bringhen+S%22">Bringhen S</searchLink>; AOU Città della Salute e della Scienza di Torino Torino Italy.<br /><searchLink fieldCode="AU" term="%22Zweegman+S%22">Zweegman S</searchLink>; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cavo+M%22">Cavo M</searchLink>; IRCCS Azienda Ospedaliero-Universitaria di Bologna Institute of Hematology 'L. e A. Seràgnoli' Bologna Italy.; Department of Medical and Surgical Sciences University of Bologna Bologna Italy.<br /><searchLink fieldCode="AU" term="%22Iqbal+S%22">Iqbal S</searchLink>; Medical Information Scientific Engagement Johnson & Johnson Innovative Medicines New York New York United States.<br /><searchLink fieldCode="AU" term="%22Hernandez+Rivas+JM%22">Hernandez Rivas JM</searchLink>; Department of Medicine, Cancer Research Center (IBMCC, USAL-CSIC), Institute of Biomedical Research of Salamanca (IBSAL) University of Salamanca Salamanca Spain.<br /><searchLink fieldCode="AU" term="%22Bruno+B%22">Bruno B</searchLink>; Division of Hematology, AOU Città della Salute e della Scienza di Torino University of Torino Torino Italy.; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kaiser+MF%22">Kaiser MF</searchLink>; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.; The Institute of Cancer Research and the Royal Marsden Hospital London United Kingdom.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; National Center for Tumor Diseases Heidelberg Heidelberg Germany.; Department of Medicine V, Heidelberg Myeloma Center University Hospital Heidelberg Heidelberg Germany.<br /><searchLink fieldCode="AU" term="%22Van+De+Donk+NWCJ%22">Van De Donk NWCJ</searchLink>; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands.<br /><searchLink fieldCode="AU" term="%22Jackson+G%22">Jackson G</searchLink>; Department of Haematology Newcastle University Newcastle Upon Tyne United Kingdom.<br /><searchLink fieldCode="AU" term="%22San-Miguel+JF%22">San-Miguel JF</searchLink>; Clínica Universidad de Navarra CIMA, IDISNA, CIBERONC (CB16/12/00369) Pamplona Spain.<br /><searchLink fieldCode="AU" term="%22Boccadoro+M%22">Boccadoro M</searchLink>; European Myeloma Network (EMN) Italy.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; Department of Medicine, Cancer Research Center (IBMCC, USAL-CSIC), Institute of Biomedical Research of Salamanca (IBSAL) University of Salamanca Salamanca Spain.<br /><searchLink fieldCode="AU" term="%22Sonneveld+P%22">Sonneveld P</searchLink>; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2025 Oct 09; Vol. 9 (10), pp. e70228. <i>Date of Electronic Publication: </i>2025 Oct 09 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41080508 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/hem3.70228 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70228 Titles: – TitleFull: Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN-HARMONY Alliance platform. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mosquera Orgueira A – PersonEntity: Name: NameFull: Gonzalez Perez MS – PersonEntity: Name: NameFull: D'Agostino M – PersonEntity: Name: NameFull: Cairns DA – PersonEntity: Name: NameFull: Larocca A – PersonEntity: Name: NameFull: Palacios JJL – PersonEntity: Name: NameFull: Wester R – PersonEntity: Name: NameFull: Bertsch U – PersonEntity: Name: NameFull: Waage A – PersonEntity: Name: NameFull: Zamagni E – PersonEntity: Name: NameFull: Pérez Míguez C – PersonEntity: Name: NameFull: Rojas Martínez JA – PersonEntity: Name: NameFull: Mai EK – PersonEntity: Name: NameFull: Crucitti D – PersonEntity: Name: NameFull: Salwender H – PersonEntity: Name: NameFull: Dall'Olio D – PersonEntity: Name: NameFull: Castellani G – PersonEntity: Name: NameFull: Piñeiro Fiel M – PersonEntity: Name: NameFull: Bringhen S – PersonEntity: Name: NameFull: Zweegman S – PersonEntity: Name: NameFull: Cavo M – PersonEntity: Name: NameFull: Iqbal S – PersonEntity: Name: NameFull: Hernandez Rivas JM – PersonEntity: Name: NameFull: Bruno B – PersonEntity: Name: NameFull: Cook G – PersonEntity: Name: NameFull: Kaiser MF – PersonEntity: Name: NameFull: Goldschmidt H – PersonEntity: Name: NameFull: Van De Donk NWCJ – PersonEntity: Name: NameFull: Jackson G – PersonEntity: Name: NameFull: San-Miguel JF – PersonEntity: Name: NameFull: Boccadoro M – PersonEntity: Name: NameFull: Mateos MV – PersonEntity: Name: NameFull: Sonneveld P IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 10 Text: 2025 Oct 09 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2572-9241 Numbering: – Type: volume Value: 9 – Type: issue Value: 10 Titles: – TitleFull: HemaSphere Type: main |
| ResultId | 1 |